Project Grant HT9425261E335
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $2.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $585,759 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The research project, "Targeting GPNMB to Improve Efficacy of CDK4/6 Inhibitors in ER+ Breast Cancer," will be conducted at Emory's Atlanta, Georgia campus. This three-year award supports advanced biomedical...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $156,049 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period October 1, 2025, through September 30, 2026. The project, titled "Establishing Epigenetic Markers in Neurofibromatosis," supports biomedical research designed to advance innovative medical solutions for military service members and the American public....
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $626,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on July 15, 2025, with a completion date of July 14, 2027. The award funds research focused on developing immune-competent three-dimensional (3D) bioprinted organoids designed to study and overcome barriers to cellular therapy for neuroblastoma treatment. This two-year...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $1.54M project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The award funds research activities focused on assessing prognoses and validating surrogate endpoints for clinical outcomes in metastatic hormone-sensitive prostate cancer. This research initiative aligns with the Defense...
- Federal Project Grant Award Summary Emory University received a $3.13 million project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded May 1, 2025, with a completion date of April 30, 2029. The award supports therapeutic research focused on the development and application of human induced pluripotent stem cell-derived lymphatic endothelial cells for treating lymphedema. This four-year research initiative will be...
- Federal Grant Award Summary Emory University's Office of Sponsored Programs received a $1.48M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) beginning September 1, 2025, and concluding August 31, 2029. The ELECTRIG project will evaluate the effects of cranial electrical stimulation therapy with responsive imaging in Gulf War Illness pain and comorbid symptoms. This research directly supports the DHA's mission to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $1.7 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) for the period July 1, 2026 through June 30, 2029. The project, titled "Targeted Disruption of the ARP300 Enhanceosome in Prostate Cancer Using Domain-Alteration Chimeras (DALTACs)," focuses on developing a novel therapeutic approach to combat prostate cancer through the use...
- Federal Grant Award Summary Beckman Research Institute of the City of Hope received a $2.136 million Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2028. The award supports developmental therapeutics research and the investigation of potential treatment strategies targeting RALBP1 (Retinoid-binding Protein 1) for castration-resistant prostate carcinoma. This...
- Federal Grant Award Summary The Regents of the University of Minnesota received a $231,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 1, 2025, with a completion date of May 31, 2027. The research project, titled "AI-Designed De Novo Miniproteins Coupled with Small Molecule Initiate Immune Cell-Mediated Eradication of PSMA-Expressing CRPC Cells," focuses on developing novel...
- Federal Grant Award Summary The University of Florida Division of Sponsored Research received a $652.4K Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2029. This award funds research on native top-down proteomics methodologies designed to improve the targeting and treatment of growth factor-mediated endocrine resistance in breast cancer. The research will be conducted at the...